(MENAFN– MarketersMEDIA)
United States – June 7, 2022 —
Tennessee Farmaceuticals announces the launch of their new pet CBD line of tinctures. Tennessee Farmaceuticals has already been established as a purveyor of CBD products with their“Sleep,”“Relief,” and“Calm” oils. Each blend has been created with a specific formulation targeting specific needs in the market.
This formulation is achieved by including botanical terpenes generally removed from the production process. Terpenes are used in nature by plants for chemical signalling. The pungent smell of pines and the sweet smell of flowers are created from terpenes. These botanical terpenes are selected for their specific properties.
The endocannabinoid system is a newly-discovered messaging system in animals. Similar to how nerves communicate in the body, the endocannabinoid system allows the body to down-regulate stress signals, lowering stress hormones and inflammation responses. CBD uses this same system to help the body control other neurotransmitters.
Tennessee Farmacaeuticals seeks to create a line of products that uses this endocannabinoid system in conjunction with the enhancement of terpenes for a more effective supplement.
The“Sleep” blend is a full-spectrum CBD oil with added terpenes selected for their sleep- enhancing qualities. The“Relief” blend is a broad-spectrum CBD oil with 100mg of hemp terpenes, encouraging relief from aches and pains….
